For those who think that space exploration offers no tangible benefits for those of us on earth, a new research discovery involving thyroid cancer may prove otherwise. In a new report appearing in the February 2014 issue ...
Jan 30, 2014
0
0
UCLA researchers have found that minority patients and those of lower socioeconomic status are far more likely to have advanced thyroid cancer when they are diagnosed with the disease than white patients and those in higher ...
Jan 9, 2014
0
0
Flame retardants are everywhere around us. Governments require manufacturers to put these chemicals into our rugs, cars, furniture, curtains, mattresses and pillows, and even many items of apparel, especially for infants. ...
Jan 7, 2014
0
0
Scientists have long sought to determine whether heredity is one of the factors responsible for increased risk of thyroid cancer, but their results have been inconclusive... until now.
Dec 4, 2013
0
0
(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nov 24, 2013
0
0
A new analysis has found that the presence of short segments of genetic material (known as microRNA) within papillary thyroid cancer tumors suggests a likelihood of recurrence after patients undergo surgery. The study, which ...
Oct 28, 2013
0
0
(Medical Xpress)—A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to ...
Oct 15, 2013
0
0
(HealthDay)—Better detection alone doesn't explain the dramatic increase in thyroid cancer cases seen in the United States over the past three decades, a new study says.
Oct 10, 2013
0
0
(HealthDay)—The cancer drug sorafenib, known by its trade name Nexavar, could have a toxic effect on the pancreas of patients who take it for extended periods.
Oct 9, 2013
0
0
Researchers at the National Institutes of Health (NIH), Bethesda, MD, have taken the first steps to determine if a protein, called Programmed Death Ligand 1 (PD-L1), can help to predict which thyroid cancer patients will ...
Oct 8, 2013
0
0
